Chợ Rẫy Hospital is the largest general hospital in Ho Chi Minh City, Vietnam; and is also the largest in Vietnam, founded in 1900 during the French colonial rule as Hôpital Municipal de Cholon.

There are 1,800 beds in Cho Ray Hospital.

During the past decade, Cho Ray Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cho Ray Hospital" #1 sponsor was "Oxford University Clinical Research Unit, Vietnam" with 2 trials, followed by "BIOTRONIK Asia Pacific Pte Ltd" with 1 trials sponsored, "Bolton Medical" with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "Fresenius Kabi" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cho Ray Hospital" #1 collaborator was "Cho Ray Hospital" with 2 trials as a collaborator, "Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam" with 2 trials as a collaborator, "Can Gio COVID Hospital, Vietnam" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator and "Chiba University, Japan" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Cho Ray Hospital" are "Abdominal Aortic Aneurysm" (1 trials), "Breast Cancer" (1 trials), "COVID-19" (1 trials), "Caloric Deficit" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Cho Ray Hospital" in a lesser frequency.

Most popular intervention types in "Cho Ray Hospital" are "Drug" (6 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amphotericin B" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials), "Bevacizumab as Avastin" (1 trials), "Bevacizumab as MYL-1402O" (1 trials) and "Chloroquine phosphate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cho Ray Hospital" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Cho Ray Hospital". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Cho Ray Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cho Ray Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".